Start Date
February 29, 2012
Primary Completion Date
August 31, 2013
Study Completion Date
February 28, 2014
Placebo
Matching placebo administered by subcutaneous injection, once weekly
Atacicept
Atacicept 5 mg administered by subcutaneous injection, once weekly
Atacicept
Atacicept 25 mg administered by subcutaneous injection, once weekly
Atacicept
Atacicept 75 mg administered by subcutaneous injection, once weekly
Atacicept
Atacicept 115 mg administered by subcutaneous injection, once weekly
Lead Sponsor
EMD Serono
INDUSTRY